Tom Hutson joined the Wyss Center in September 2022 as Research Scientist, then became Group Leader in February 2024. His mission is to develop innovative cell-type targeted optogenetic therapies for nervous system disorders that combine neuroscience and bioengineering.

Tom received his PhD in Neuroscience from King’s College London and then undertook positions at Imperial College London and EPFL where he leveraged molecular systems biology approaches to uncover neuronal populations essential for the recovery of sensorimotor function and developed bio-compatible optoelectronic devices to target specific neuronal populations. Tom brings extensive knowledge in translational research and an established background in gene-therapy mediated neuromodulation in regenerative medicine.